kevin niswender

July 9, 2015

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

By VUMC News and Communications
chip closeup
November 18, 2014

Vanderbilt’s neurovascular chip project moves into new phase

Vanderbilt researchers will play a key role in the second phase of the federal “tissue chip for drug screening” program.

By VUMC News and Communications
hamburger and fries
June 2, 2014

Vanderbilt study supports notion ‘You are what you eat’

An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.

By Bill Snyder
April 18, 2013

Vanderbilt’s Hong, Niswender elected to ASCI

Charles Hong, M.D., Ph.D., and Kevin Niswender, M.D., Ph.D., have been elected to membership in the American Society of Clinical Investigation (ASCI), one of the nation’s most respected medical honor societies.

By Bill Snyder
microbrain
July 24, 2012

Vanderbilt-led team to develop ‘microbrain’ to improve drug testing

Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.

By VUMC News and Communications
1 2